ETP provider GraniteShares, which offers a range of 3x short and 3x leveraged ETPs on popular UK, US, and French stocks, says the investment outlook for the healthcare sector is positive.
In the year to 24th November 2021, the AstraZeneca share price had increased by 18.8 per cent, and the corresponding figure for 3x Long AstraZeneca Daily ETP (3LAZ) was 41.1 per cent.
The firm says: “As we enter a more difficult environment, moving beyond rapid recovery and facing greater uncertainty, the healthcare sector may provide some opportunity for investors. Traditionally it has performed well in mid-cycle environments, which we currently face.”
Will Rhind, CEO and founder of GraniteShares says: “Leading healthcare companies that are able to maintain earnings momentum through a period of slowing economic growth, may exhibit lower volatility and defensive growth characteristics. They can often deliver this because of the necessity of many of their products and services.
“During the crisis, the sector has also made huge strides from a technological point of view, improving levels of efficiency and delivering new product innovations, which should help drive profitability.”